17-AAG |
17-(allylamino)-17-demethoxygeldanamycin |
17-DMAG |
17-desmethoxy-17-N,N-dimethylaminoethylaminogeldanamycin |
ADP |
adenosine diphosphate |
Akt |
serine-threonine protein kinase |
AMPK |
AMP-activated protein kinase |
ATP |
adenosine triphosphate |
ATPase |
adenosine triphosphatase |
Bcl-2 |
B-cell lymphoma 2 protein |
BRAF |
B-Raf proto-oncogene |
CTD |
C-terminal domain |
CTLA-4 |
cytotoxic T-lymphocyte-associated protein 4 |
EGCG |
epigallocatechin gallate |
EGFR |
epidermal growth factor receptor |
EMT |
epithelial mesenchymal transition |
EphA2 |
ephrin type-A receptor 2 |
GDA |
geldanamycin |
GRP94 |
glucose related protein |
HER |
human epidermal growth factor receptor |
HIF-1α |
hypoxia-inducible factor 1-alpha |
HSE |
heat shock element |
HSF1 |
heat shock factor 1 |
HSP |
heat shock proteins |
JAK2 |
Janus kinase 2 |
KRAS |
K-Ras proto-oncogene |
MAPK |
mitogen-activated protein kinase |
MCL-1 |
induced myeloid leukemia cell differentiation protein |
MDM2 |
mouse double minute 2 homolog |
MEK |
mitogen-activated protein kinase |
mTOR |
mammalian target of rapamycin |
NBD |
nucleotide-binding domain |
NSCLC |
non-small cell lung cancer |
PAC-1 |
procaspase activating compound 1 |
PES |
2-phenylethynesulfonamide, pifithrin-μ |
PD-1 |
programmed cell death protein 1 |
PD-L1 |
programmed death-ligand 1 |
pTEFb |
positive transcription elongation factor b |
RDC |
radicicol |
TFIIH |
transcription factor II human |
XPB |
xeroderma pigmentosum type B |